β¨ Health and Legal Notices
18 APRIL 2013
NEW ZEALAND GAZETTE, No. 44
1361
Schedule
Product: Lovir
Active Ingredient: Aciclovir 200mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Lovir
Active Ingredient: Aciclovir 400mg
Dosage Form: Dispersible Tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Lovir
Active Ingredient: Aciclovir 800mg
Dosage Form: Dispersible tablet
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturers: Ranbaxy Laboratories Limited, Himachal Pradesh, India
Ranbaxy Laboratories Limited, Madhya Pradesh, India
Product: Panadol
Active Ingredient: Paracetamol 125mg
Dosage Form: Suppository
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Product: Panadol
Active Ingredient: Paracetamol 250mg
Dosage Form: Suppository
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Product: Panadol Children 3 months - 12 years
Active Ingredient: Paracetamol 24mg/mL
Dosage Form: Oral suspension
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer GlaxoSmithKline Australia Pty Limited, Ermington, Australia
Dated this 11th day of April 2013.
DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2211
Inland Revenue
JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue.
Tax Administration Act 1994
Notice of Determination Regarding Type of Interest in a Foreign Investment Fund and Use of Fair Dividend Rate Method
-
This is a notice made under section 91AAO(5) of the Tax Administration Act 1994 of a determination made by the Commissioner of Inland Revenue under section 91AAO(1) of that Act.
-
Determination FDR 2013/01 was made on 27 March 2013 permitting certain portfolio investment entity funds managed by New Zealand Funds Management Limited to use the fair dividend rate method to calculate foreign investment fund income from Ospraie Commodity Fund Limited, for the 2012β2013 and subsequent income years.
-
The determination will appear in Inland Revenueβs Tax Information Bulletin, Vol. 25, No. 4, of May 2013 and will also be available on the Inland Revenue website.
go2181
Internal Affairs
Marriage Act 1955
Marriage (Approval of Organisations) Notice No. 10
Pursuant to the Marriage Act 1955, the Registrar-General of Marriages hereby gives notice as follows.
Notice
-
This notice may be cited as the Marriage (Approval of Organisations) Notice No. 10.
-
The organisation specified in the Schedule hereto is hereby declared to be an approved organisation for the purpose of the Marriage Act 1955.
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare11 April 2013
Medicines, Pharmaceuticals, Approval, Distribution
- DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π° Tax Administration Notice Regarding Foreign Investment Fund
π° Finance & RevenueTax Administration Act 1994, Foreign Investment Fund, Fair Dividend Rate Method
- JOHN TREZISE, Investigations Manager, Investigations and Advice, Inland Revenue
ποΈ Approval of Marriage Organisation
ποΈ Governance & Central AdministrationMarriage Act 1955, Approved Organisation, Registrar-General of Marriages
- Registrar-General of Marriages
NZ Gazette 2013, No 44